InspireMD Inc (NSPR) has disclosed a new risk, in the Demand category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InspireMD Inc.’s growth is tightly tied to the true size of the carotid artery stenting (CAS) market and its ability to drive sustained adoption among hospitals and physicians. If its market estimates prove overstated or if physicians remain slow to change entrenched practices, its revenue trajectory and long‑term profitability could be materially constrained.
The average NSPR stock price target is $5.50, implying 207.26% upside potential.
To learn more about InspireMD Inc’s risk factors, click here.